Shibani Mukerji News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shibani mukerji. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shibani Mukerji Today - Breaking & Trending Today

The omicron BA.2 variant in Florida: What you need to know to stay safe

In Florida, where positivity rates are low, many people are taking off their masks and returning to indoor spaces like restaurants and theaters. As BA.2 accounts for more cases in Florida, attention is on whether another wave will hit the state and how to move forward while staying safe. ....

United States , University Of Florida , Ira Longini , Merck Molnupiravir , Scott Gottlieb , Anthony Fauci , Eric Topol , Shibani Mukerji , Scripps Research Institute , World Health Organization , Harvard Medical School , Health Report Newsletter , Spring Break , South Florida Sun Sentinel ,

Omicron subvariant in Florida: What to know to stay safe - South Florida Sun-Sentinel

In Florida, where positivity rates are low, many people are taking off their masks and returning to indoor spaces like restaurants and theaters. As BA.2 accounts for more cases in Florida, attention is on whether another wave will hit the state and how to move forward while staying safe. ....

United States , University Of Florida , Ira Longini , Merck Molnupiravir , Scott Gottlieb , Anthony Fauci , Eric Topol , Shibani Mukerji , Scripps Research Institute , World Health Organization , Harvard Medical School , Your Health Newsletter , Spring Break , South Florida Sun Sentinel ,

Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID

Background and Objectives Recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection appears exponential, leaving a tail of patients reporting various long COVID symptoms including unexplained fatigue/exertional intolerance and dysautonomic and sensory concerns. Indirect evidence links long COVID to incident polyneuropathy affecting the small-fiber (sensory/autonomic) axons.

Methods We analyzed cross-sectional and longitudinal data from patients with World Health Organization (WHO)-defined long COVID without prior neuropathy history or risks who were referred for peripheral neuropathy evaluations. We captured standardized symptoms, examinations, objective neurodiagnostic test results, and outcomes, tracking participants for 1.4 years on average.

Results Among 17 patients (mean age 43.3 years, 69% female, 94% Caucasian, and 19% Latino), 59% had ≥1 test interpretation confirming neuropathy. These included 63% (10/16) of skin biopsies, 17% (2/12) ....

Khosro Farhad , Yair Mina , Pedro Steven Buarque , Joseph Tornabene , Matthewp Wicklund , Sara Dehbashi , Yancy Seamans , Lisa Paul , Madeleinec Klein , Jennifer Curtin , Shibani Mukerji , Division Of Intramural Research , National Institutes Of Health , World Health Organization , Department Of Neurology Thomas Jefferson University , Objectives Recovery , Protocol Approvals , National Institutes , Intramural Research , Thomas Jefferson University , Pedro Steven Buarque De Macedo , Article Processing Charge ,